Mayda Gursel

Mayda Gursel

Orta Dogu Teknik Üniversitesi

H-index: 40

Asia-Turkey

About Mayda Gursel

Mayda Gursel, With an exceptional h-index of 40 and a recent h-index of 22 (since 2020), a distinguished researcher at Orta Dogu Teknik Üniversitesi, specializes in the field of Immunology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine

5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Testing in times of COVID-19: legacy & unfinished agenda

Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic

Should we vaccinate against long-COVID?

Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency

Low density granulocytes and dysregulated neutrophils driving autoinflammatory manifestations in NEMO deficiency

Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemia

Mayda Gursel Information

University

Position

Department of Biological Sciences

Citations(all)

10699

Citations(since 2020)

5419

Cited By

7164

hIndex(all)

40

hIndex(since 2020)

22

i10Index(all)

62

i10Index(since 2020)

37

Email

University Profile Page

Orta Dogu Teknik Üniversitesi

Google Scholar

View Google Scholar Profile

Mayda Gursel Skills & Research Interests

Immunology

Top articles of Mayda Gursel

Title

Journal

Author(s)

Publication Date

Immunogenicity and Protective Capacity of CpG ODN Adjuvanted Alum Adsorbed Bivalent Meningococcal Outer Membrane Vesicle Vaccine

International immunology

Tugce Canavar Yildirim

Yasemin Ozsurekci

Muzaffer Yildirim

Irem Evcili

Volkan Yazar

...

2024/3/27

5, 6-dimethylxanthenone-4-acetic acid (DMXAA), a partial STING agonist, competes for human STING activation

Frontiers in Immunology

Burcu Temizoz

Takayuki Shibahara

Kou Hioki

Tomoya Hayashi

Kouji Kobiyama

...

2024/3/12

Testing in times of COVID-19: legacy & unfinished agenda

Vaccine Insights

Carolina Batista

Yanis Ben Amor

Onder Ergonul

Peter Figueroa

Sarah C Gilbert

...

2023/8/23

Vaccine supply chains: priority areas of action emerging from the COVID-19 pandemic

Vaccine Insights

Ravi Anupindi

Mayda Gursel

2023/3/21

Should we vaccinate against long-COVID?

Vaccine Insights

Peter Hotez

Carolina Batista

Yanis Ben Amor

Onder Ergonul

Peter Figueroa

...

2022/6/3

Expanding the clinical and immunological phenotypes and natural history of MALT1 deficiency

Journal of clinical immunology

Asena Pinar Sefer

Hassan Abolhassani

Franziska Ober

Basak Kayaoglu

Sevgi Bilgic Eltan

...

2022/4

Low density granulocytes and dysregulated neutrophils driving autoinflammatory manifestations in NEMO deficiency

Journal of Clinical Immunology

Naz Surucu Yilmaz

Sevgi Bilgic Eltan

Basak Kayaoglu

Busranur Geckin

Raul Jimenez Heredia

...

2022/4/1

Leishmania kinetoplast DNA contributes to parasite burden in infected macrophages: Critical role of the cGAS-STING-TBK1 signaling pathway in macrophage parasitemia

Frontiers in Immunology

Ismail Yilmaz

EMRE DÜNÜROĞLU

İHSAN AYANOĞLU

EMRE İPEKOĞLU

Muzaffer Yildirim

...

2022

The silent and dangerous inequity around access to COVID-19 testing: a call to action

EClinicalMedicine

Carolina Batista

Peter Hotez

Yanis Ben Amor

Jerome H Kim

David Kaslow

...

2022/1/1

Why vaccinate children against COVID-19?

Vaccine Insights

David C Kaslow

Carolina Batista

Maria Elena Bottazzi

Onder Ergonul

J Peter Figueroa

...

2022/10/13

Development and preclinical evaluation of virus‐like particle vaccine against COVID‐19 infection

Allergy

Ismail Cem Yilmaz

Emre Mert Ipekoglu

Artun Bulbul

Nilsu Turay

Muzaffer Yildirim

...

2022/1

Healthcare in global crisis: preparations needed during the COVID-19 pandemic

Vaccine Insights

Bhavna Lall

Dhruva Chaudhry

Shmuel Shoham

Onder Ergonul

Suneela Garg

...

2022/9/23

Virus like particle formation by using 4 structural proteins of SARS-Cov-2 and investigation of its effectiveness among wild type and prefusion stabilized spike variants

European Journal of Immunology

N Turay

M Yildirim

TC Yildirim

B Saraydar

KT Bildik

...

2021

Manufacturing of a SARS-CoV-2 virus-like particle vaccine adjuvanted with K3 CpG oligodeoxynucleotide and alhydrogel for phase 1/2 clinical trials

European Journal of Immunology

Artun Bulbul

Ismail Cem Yilmaz

Naz Yilmaz

Nilsu Turay

Emre Mert Ipekoglu

...

2021

Urgent needs to accelerate the race for COVID-19 therapeutics

EClinicalMedicine

Carolina Batista

Shmuel Shoham

Onder Ergonul

Peter Hotez

Maria Elena Bottazzi

...

2021/6/1

COVID-19 content collection

The Lancet

William M Souza

Mariene R Amorim

Renata Sesti-Costa

Lais D Coimbra

Natalia S Brunetti

...

2021/7/7

Ex vivo Th-1 biasing T cell responses in alum-adsorbed SARS-CoV-2 inactivated virus vaccine adjuvanted with K-type CpG ODN

European Journal of Immunology

EM Ipekoglu

M Yildirim

TC Yildirim

B Saraydar

KT Bildik

...

2021

Helper T cell responses in SARS-CoV-2 virus like particle vaccinated mice

European Journal of Immunology

N Guvencli

M Yildirim

TC Yildirim

B Saraydar

KT Bildik

...

2021

Beyond the jab: a need for global coordination of pharmacovigilance for COVID-19 vaccine deployment

EClinicalMedicine

Denise Naniche

Peter Hotez

Maria Elena Bottazzi

Onder Ergonul

J Peter Figueroa

...

2021/6/1

Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed

PLoS medicine

J Peter Figueroa

Peter J Hotez

Carolina Batista

Yanis Ben Amor

Onder Ergonul

...

2021/9/13

See List of Professors in Mayda Gursel University(Orta Dogu Teknik Üniversitesi)